Theriva Biologics Inc. (TOVX)
TOVX trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2157
-1.69% on the day
Market cap
$9.9M
Nano cap
Revenue
No annual revenue filed since the period ending 2011-12-31
Net income
No annual revenue filed since the period ending 2011-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TOVX on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000894158 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials
No annual revenue filed since the period ending 2011-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-03 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report FORM 8-K | 8-K | 2026-08-11 |
| Latest proxy | PRE 14A | 2026-10-09 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | $0.4274 | -15.38% | $9.7M |
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| BFRG | Bullfrog AI Holdings Inc. | $0.5689 | -2.55% | $10.5M |
| LTRN | Lantern Pharma Inc. | $0.7107 | -3.57% | $10.6M |
| BLRX | BioLineRx Ltd. | $2.17 | 0.00% | $10.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier